Skip to main content

CORRECTION article

Front. Oncol., 10 February 2022
Sec. Pharmacology of Anti-Cancer Drugs
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.859596

Corrigendum: Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database

This article is a correction to:

  1. Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database

    1. Read original article
Zhiming JiaoZhiming Jiao1Zhanchun FengZhanchun Feng1Ziqi YanZiqi Yan1Jinwen ZhangJinwen Zhang2Gang LiGang Li1Ganyi Wang,Ganyi Wang3,4Qianyu WangQianyu Wang1Da Feng*Da Feng5*
  • 1School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • 2Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • 3Medical Products Administration and Center for Adverse Drug Reaction (ADR) Monitoring of Henan, Zhengzhou, China
  • 4College of Public Administration, Huazhong University of Science and Technology, Wuhan, China
  • 5School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

A Corrigendum on
Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database

by Jiao Z, Feng Z, Yan Z, Zhang J, Li G, Wang G, Wang Q and Feng D (2021) Front. Oncol. 11:807171. doi: 10.3389/fonc.2021.807171

There is an error in the Funding statement. The correct number for the National Youth Natural Science Foundation of China is 71804052.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: pharmacovigilance, drug monitoring, adverse drug reaction reporting systems, pediatric, medical oncology

Citation: Jiao Z, Feng Z, Yan Z, Zhang J, Li G, Wang G, Wang Q and Feng D (2022) Corrigendum: Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database. Front. Oncol. 12:859596. doi: 10.3389/fonc.2022.859596

Received: 21 January 2022; Accepted: 24 January 2022;
Published: 10 February 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Jiao, Feng, Yan, Zhang, Li, Wang, Wang and Feng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Da Feng, fengda@hust.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.